大家在查： eye line igbn desecrating 布鲁斯·阿 2004-December EarlyLearn Crocodilurus stocks markets 09.04 同同

MarkFishman

MarkFishman

诺华生物医学研究所总裁费思民（MarkFishman）认为此举并没有成本优势。诺华公司最初将主要依靠中国的归国科学家。

Mark Fishman, the former Harvard academic who is head of research at Novartis, said there was little cost advantage to the move.